Challenges to the optimisation of cystic fibrosis exacerbation treatment outcomes

被引:0
|
作者
Goss, Christopher H. [1 ,2 ,3 ]
Vandevanter, Donald R. [4 ]
机构
[1] Univ Washington, Dept Med, Seattle, WA 98195 USA
[2] Univ Washington, Dept Pediat, Seattle, WA 98195 USA
[3] Seattle Children s Res Inst, CF Therapeut Dev Network Coordinating Ctr, Seattle, WA 98101 USA
[4] Case Western Reserve Univ, Sch Med, Dept Pediat, Cleveland, OH USA
基金
美国国家卫生研究院;
关键词
PULMONARY EXACERBATIONS; ANTIBIOTIC-TREATMENT; TRIAL; PLACEBO;
D O I
10.1183/13993003.00858-2024
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Evidence continues to build regarding management of pulmonary exacerbation in cystic fibrosis. This editorial comments on the work by Waters and colleagues, noting evidence continues to build regarding the lack of efficacy of steroids in exacerbation. © 2024 European Respiratory Society. All rights reserved.
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Treatment of Cystic Fibrosis Time for a New Paradigm?
    Bush, Andrew
    CHEST, 2009, 136 (05) : 1197 - 1199
  • [22] Standardized Treatment of Pulmonary Exacerbations (STOP) study: Physician treatment practices and outcomes for individuals with cystic fibrosis with pulmonary Exacerbations
    West, Natalie E.
    Beckett, Valeria V.
    Jain, Raksha
    Sanders, Don B.
    Nick, Jerry A.
    Heltshe, Sonya L.
    Dasenbrook, Elliott C.
    VanDevanter, Donald R.
    Solomon, George M.
    Goss, Christopher H.
    Flume, Patrick A.
    JOURNAL OF CYSTIC FIBROSIS, 2017, 16 (05) : 600 - 606
  • [23] The demographics of adverse outcomes in cystic fibrosis
    McGarry, Meghan E.
    Williams, Wadsworth A., II
    McColley, Susanna A.
    PEDIATRIC PULMONOLOGY, 2019, 54 : S74 - S83
  • [24] A randomised trial of hypertonic saline during hospitalisation for exacerbation of cystic fibrosis
    Dentice, Ruth L.
    Elkins, Mark R.
    Middleton, Peter G.
    Bishop, Jennifer R.
    Wark, Peter A. B.
    Dorahy, Douglas J.
    Harmer, Christopher J.
    Hu, Honghua
    Bye, Peter T. P.
    THORAX, 2016, 71 (02) : 141 - 147
  • [25] Cystic Fibrosis Diagnosis and Treatment
    Naehrig, Susanne
    Chao, Cho-Ming
    Naehrlich, Lutz
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2017, 114 (33-34): : 564 - +
  • [26] The effect of oral and intravenous antimicrobials on pulmonary exacerbation recovery in cystic fibrosis
    VanDevanter, Eden J.
    Heltshe, Sonya L.
    Skalland, Michelle
    Lechtzin, Noah
    Nichols, Dave
    Goss, Christopher H.
    JOURNAL OF CYSTIC FIBROSIS, 2021, 20 (06) : 932 - 936
  • [27] Diagnosis and treatment of cystic fibrosis
    Koch, C
    Holby, N
    RESPIRATION, 2000, 67 (03) : 239 - 247
  • [28] Cost of Hospitalizations due to Exacerbation in Patients with Non-Cystic Fibrosis Bronchiectasis
    de la Rosa Carrillo, David
    Navarro Rolon, Annie
    Giron Moreno, Rosa Maria
    Montull Veiga, Beatriz
    Olveira Fuster, Casilda
    Padilla Galo, Alicia
    Prados Sanchez, Concepcion
    Quintana Gallego, Esther
    Sibila Vidal, Oriol
    Celorrio Jimenez, Nuria
    Ruiz Pena, Antonio
    Torres Marti, Antoni
    Aviles Ingles, Maria Jesus
    Blanco Aparicio, Marina
    Garcia-Clemente, Marta
    Golpe Gomez, Rafael
    Gomez Bonilla, Ainhoa
    Gomez Gonzalez, Cristina
    Leal Arranz, Maria Victoria
    Minguez Clemente, Patricia
    Lopez Muniz, Belen
    Maiz Carro, Luis
    Pando Sandoval, Ana
    Rodriguez Hermosa, Juan Luis
    Uranga Echeverria, Ane
    Nunez Ares, Ana
    Lopez Roldan, Lorena
    Abellan Martinez, Carmen
    Martinez Garcia, Abel Jesus
    Michel de la Rosa, Francisco Javier
    Godoy Mayoral, Raul
    Angel Martinez-Garcia, Miguel
    RESPIRATION, 2018, 96 (05) : 406 - 416
  • [29] Special considerations for the treatment of pulmonary exacerbations in children with cystic fibrosis
    Waters, Valerie
    Stanojevic, Sanja
    Ratjen, Felix
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2016, 10 (11) : 1221 - 1228
  • [30] Novel treatment modalities for cystic fibrosis
    van Koningsbruggen-Rietschel, Silke
    PNEUMOLOGE, 2019, 16 (02): : 88 - 97